Source:http://linkedlifedata.com/resource/pubmed/id/20427723
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-6-25
|
pubmed:abstractText |
We evaluated the effects of intracerebroventricular (icv) infusion of Na(+)-rich artificial cerebrospinal fluid (aCSF), with or without the mineralocorticoid receptor (MR) blocker spironolactone, on epithelial Na(+) channel (ENaC) subunits and regulators, such as MR, serum/glucocorticoid-inducible kinase 1, neural precursor cells expressed developmentally downregulated 4-like gene, 11beta-hydroxylase, and aldosterone synthase, in brain regions of Wistar rats. The effects of icv infusion of the amiloride analog benzamil on brain tissue and CSF Na(+) concentration ([Na(+)]) were also assessed. In the choroid plexus and ependyma of the anteroventral third ventricle, ENaC subunits are present in apical and basal membranes. Na(+)-rich aCSF increased beta-ENaC mRNA and immunoreactivity in the choroid plexus and increased alpha- and beta-ENaC immunoreactivities in the ependyma. Na(+)-rich aCSF increased alpha- and beta-ENaC-gold-labeled particles in the microvilli of the choroid plexus and in basolateral membranes of the ependyma. Spironolactone only prevented the increase in beta-ENaC immunoreactivity in the choroid plexus and ependyma. In the supraoptic nucleus, paraventricular nucleus, and subfornical organ, Na(+)-rich aCSF did not affect mRNA expression levels of the studied genes. Benzamil significantly increased CSF [Na(+)] in the control, but not Na(+)-rich, aCSF group. In contrast, benzamil prevented the increase in hypothalamic tissue [Na(+)] by Na(+)-rich aCSF. These results suggest that CSF Na(+) upregulates ENaC expression in the brain epithelia, but not in the neurons of hypothalamic nuclei. ENaC in the choroid plexus and ependyma appear to contribute to regulation of Na(+) homeostasis in the brain.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone Synthase,
http://linkedlifedata.com/resource/pubmed/chemical/Amiloride,
http://linkedlifedata.com/resource/pubmed/chemical/Epithelial Sodium Channel,
http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Mineralocorticoid,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium, Dietary,
http://linkedlifedata.com/resource/pubmed/chemical/Spironolactone,
http://linkedlifedata.com/resource/pubmed/chemical/benzamil,
http://linkedlifedata.com/resource/pubmed/chemical/spironolactone receptor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1522-1490
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
299
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
R222-33
|
pubmed:meshHeading |
pubmed-meshheading:20427723-Aldosterone Synthase,
pubmed-meshheading:20427723-Amiloride,
pubmed-meshheading:20427723-Animals,
pubmed-meshheading:20427723-Biological Transport,
pubmed-meshheading:20427723-Brain,
pubmed-meshheading:20427723-Choroid Plexus,
pubmed-meshheading:20427723-Epithelial Sodium Channel,
pubmed-meshheading:20427723-Epithelium,
pubmed-meshheading:20427723-Glucocorticoids,
pubmed-meshheading:20427723-Hypothalamus,
pubmed-meshheading:20427723-Male,
pubmed-meshheading:20427723-Paraventricular Hypothalamic Nucleus,
pubmed-meshheading:20427723-RNA, Messenger,
pubmed-meshheading:20427723-Random Allocation,
pubmed-meshheading:20427723-Rats,
pubmed-meshheading:20427723-Rats, Wistar,
pubmed-meshheading:20427723-Receptors, Mineralocorticoid,
pubmed-meshheading:20427723-Sodium,
pubmed-meshheading:20427723-Sodium, Dietary,
pubmed-meshheading:20427723-Spironolactone
|
pubmed:year |
2010
|
pubmed:articleTitle |
Effects of central sodium on epithelial sodium channels in rat brain.
|
pubmed:affiliation |
Hypertension Unit, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|